Showing 1489 results
-
Pulse Update /
-
Featured News /
We are partnering with the Friedrich Miescher Institute on more than 50 research projects to improve and extend people’s lives.
-
Story /Novartis has acquired Kate Therapeutics to further enhance and strengthen our ongoing efforts to advance gene therapies for patients.
-
Pulse Update /
-
Featured News /It’s time to change the conversation. Patient inspired and community led, Sound Up aims to empower people affected by lung cancer in raising the volume to vocally self-advocate.
-
Story /One patient’s story reveals the hidden obstacles to better health – and opportunities to help clear them.
-
Press release /Biologics License Application (BLA) is supported by analytical, pre-clinical and clinical data, proposed biosimilar trastuzumab developed by EirGenix, Inc. Trastuzumab is monoclonal…
-
Press release /Submission is supported by comprehensive package of analytical, pre-clinical and clinical data, proposed biosimilar trastuzumab developed by EirGenix, Inc.Breast cancer is one of most common types of…